Tailored theranostic apolipoprotein E3 porphyrin-lipid nanoparticles target glioblastoma-Reference-Cited by-同舟云学术

Tailored theranostic apolipoprotein E3 porphyrin-lipid nanoparticles target glioblastoma

Published:2017 Issue:8 Volume:8 Page:5371-5384
ISSN:2041-6520
Container-title:Chemical Science
language:en
Short-container-title:Chem. Sci.

Author:

Rajora M. A.¹²³⁴⁵,Ding L.¹²³⁴,Valic M.¹²³⁴⁵,Jiang W.¹²³⁴,Overchuk M.¹²³⁴⁵,Chen J.¹²³⁴,Zheng G.¹²³⁴⁵^ORCID

Affiliation:

1. Princess Margaret Cancer Centre

2. University Health Network

3. Toronto

4. Canada

5. Institute of Biomaterials and Biomedical Engineering

Abstract

Size-controlled discoidal and cholesteryl oleated-loaded spherical, intrinsically multimodal porphyrin-lipid nanoparticles targeted glioblastoma via apoE3 and LDLR.

Funder

Natural Sciences and Engineering Research Council of Canada

Canada Foundation for Innovation

Canadian Institutes of Health Research

Princess Margaret Cancer Foundation

Terry Fox Research Institute

Canadian Cancer Society Research Institute

Publisher

Royal Society of Chemistry (RSC)

Subject

General Chemistry

Link

http://pubs.rsc.org/en/content/articlepdf/2017/SC/C7SC00732A

Reference60 articles.

1. CBTRUS Statistical Report: Primary Brain and Central Nervous System Tumors Diagnosed in the United States in 2007-2011

2. Effective transvascular delivery of nanoparticles across the blood-brain tumor barrier into malignant glioma cells

3. Physiologic upper limit of pore size in the blood-tumor barrier of malignant solid tumors

4. Vaso-occlusive and prothrombotic mechanisms associated with tumor hypoxia, necrosis, and accelerated growth in glioblastoma

5. Cost of Migration: Invasion of Malignant Gliomas and Implications for Treatment

Cited by 73 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The piper at the gates of brain: A systematic review of surface modification strategies on lipid nanoparticles to overcome the Blood-Brain-Barrier;International Journal of Pharmaceutics;2024-09

2. Systemic Brain Delivery of Oligonucleotide Therapeutics Enhanced by Protein Corona‐Assisted DNA Cubes;Small Methods;2024-08-02

3. Recent advances in spatio-temporally controllable systems for management of glioma;Asian Journal of Pharmaceutical Sciences;2024-08

4. Application of biomimetic nanovaccines in cancer immunotherapy: A useful strategy to help combat immunotherapy resistance;Drug Resistance Updates;2024-07

5. An Overview on the Physiopathology of the Blood–Brain Barrier and the Lipid-Based Nanocarriers for Central Nervous System Delivery;Pharmaceutics;2024-06-22